Thermo Fisher Scientific Inc. (TMO)

NYSE: TMO · Real-Time Price · USD

Compare

565.22

-4.87 (-0.85%)

At close: Feb 4, 2026, 4:00 PM EST

563.00

-2.22 (-0.39%)

After-hours: Feb 4, 2026, 7:44 PM EST

Thermo Fisher Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	44,556	42,879	42,857	44,915	39,211
Revenue Growth (YoY)	3.91%	0.05%	-4.58%	14.55%	21.70%
Cost of Revenue	25,984	25,130	25,662	25,944	19,573
Gross Profit	18,572	17,749	17,195	18,971	19,638
Selling, General & Admin	7,073	8,595	8,381	8,940	7,857
Research & Development	1,397	1,390	1,337	1,471	1,406
Amortization of Goodwill & Intangibles	1,730	-	-	-	-
Other Operating Expenses	-	30	1	-	3
Operating Expenses	10,200	10,015	9,719	10,411	9,266
Operating Income	8,372	7,734	7,476	8,560	10,372
Interest Expense	-1,419	-1,390	-1,375	-726	-536
Interest & Investment Income	993	1,078	879	272	43
Earnings From Equity Investments	-41	-42	-59	-172	-4
Currency Exchange Gain (Loss)	-	-16	-29	102	162
Other Non Operating Income (Expenses)	-4	5	5	-35	-161
EBT Excluding Unusual Items	7,901	7,369	6,897	8,001	9,876
Merger & Restructuring Charges	-	-104	-220	-68	-72
Gain (Loss) on Sale of Investments	-	21	-46	-161	66
Asset Writedown	-	-252	-219	-46	-122
Legal Settlements	-	-	-19	-	-
Other Unusual Items	-633	-39	-154	-63	-911
Pretax Income	7,268	6,995	6,239	7,663	8,837
Income Tax Expense	547	657	284	703	1,109
Earnings From Continuing Operations	6,721	6,338	5,955	6,960	7,728
Net Income to Company	6,721	6,338	5,955	6,960	7,728
Minority Interest in Earnings	-17	-3	40	-10	-3
Net Income	6,704	6,335	5,995	6,950	7,725
Net Income to Common	6,704	6,335	5,995	6,950	7,725
Net Income Growth	5.83%	5.67%	-13.74%	-10.03%	21.18%
Shares Outstanding (Basic)	377	382	386	392	394
Shares Outstanding (Diluted)	378	383	388	394	397
Shares Change (YoY)	-1.31%	-1.29%	-1.52%	-0.76%	-0.50%
EPS (Basic)	17.78	16.58	15.53	17.73	19.61
EPS (Diluted)	17.74	16.53	15.45	17.63	19.46
EPS Growth	7.32%	6.99%	-12.37%	-9.40%	21.93%
Free Cash Flow	6,293	7,267	6,927	6,911	6,789
Free Cash Flow Per Share	16.65	18.97	17.85	17.54	17.10
Dividend Per Share	1.720	1.560	1.400	1.200	1.040
Dividend Growth	10.26%	11.43%	16.67%	15.38%	18.18%
Gross Margin	41.68%	41.39%	40.12%	42.24%	50.08%
Operating Margin	18.79%	18.04%	17.44%	19.06%	26.45%
Profit Margin	15.05%	14.77%	13.99%	15.47%	19.70%
Free Cash Flow Margin	14.12%	16.95%	16.16%	15.39%	17.31%
EBITDA	11,152	10,842	10,882	11,941	12,964
EBITDA Margin	25.03%	25.29%	25.39%	26.59%	33.06%
D&A For EBITDA	2,780	3,108	3,406	3,381	2,592
EBIT	8,372	7,734	7,476	8,560	10,372
EBIT Margin	18.79%	18.04%	17.44%	19.06%	26.45%
Effective Tax Rate	7.53%	9.39%	4.55%	9.17%	12.55%
Revenue as Reported	-	42,879	42,857	44,915	39,211

Updated Jan 29, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q